Stuart M. Langbein
Hogan Lovells
Articles
CMS issues Medicare Part B and Part D inflation rebate guidance
USA - February 13 2023 On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents implementing the Medicare Part B…
Alice Valder Curran, Mahmud Brifkani, Ken Choe, Beth Halpern, James Huang, Katie Kramer, Samantha D. Marshall, Rianna Modi, Kathleen A. Peterson, Beth L. Roberts, Abdie Santiago
Senate passes drug pricing legislation
USA - August 8 2022 On August 7, 2022, the Senate passed the proposed Inflation Reduction Act of 2022, which includes a number of significant drug pricing-related…
Alice Valder Curran, Melissa K. Bianchi, Mahmud Brifkani, Ken Choe, Elizabeth (Beth) Halpern, Ashley Ifeadike, Samantha D. Marshall, Kathleen A. Peterson, Beth L. Roberts, Cybil Roehrenbeck, Anna Weinstein
World Stem Cell Summit panel cautions over stepped up HCT/P enforcement, reimbursement issues
USA - June 30 2022 Speaking at the World Stem Cell Summit hosted by the Regenerative Medicine Foundation last week, Hogan Lovells partners Mike Druckman, Stuart Langbein…
Thomas Beimers, Mike Druckman, Sally Gu, James Huang, Sarah Thompson Schick
Panelists discuss present & future reimbursement mechanisms for AI health care products
USA - June 28 2022 At our recent Health Care AI Law and Policy Summit, Hogan Lovells partner Stuart Langbein moderated a panel discussion on AI policy and reimbursement…
Immunoglobulin Therapies in the US: How they are used, a Roundtable Report
USA - May 4 2022 On September 9, 2021, a panel of experts convened To discuss the use of immunoglobulin (Ig) therapies, Detail the therapeutic benefits of Ig therapies…
